Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol, sodium salt and palmitic acid

EU orphan designation number: EU/3/11/927   
Active ingredient: Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol, sodium salt and palmitic acid
Indication: Treatment of cystic fibrosis
Sponsor: Pharm Research Associates (UK) Limited
Pacific House, Imperial Way, Reading, Berkshire RG2 0TD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/10/2011 Centralised Orphan - Designation EMA/OD/032/11 (2011)7904 of 27/10/2011